source
- GSK to invest up to $110 million in expanded AI drug-discovery partnership with Relation TherapeuticsGSK announced it will pay Relation Therapeutics up to $110 million to broaden their existing collaboration that uses artificial‑intelligence models to identify new drug candidates. The expanded ag…
- BMS CEO says firm not pressured to pursue acquisitions despite quiet M&A yearBMS chief executive Chris Boerner told analysts on the second‑quarter earnings call that the company’s robust late‑stage pipeline means it does not feel any compulsion to chase deals. The firm has…